Come up with a name for your new list and we'll add to it:
Indi Molecular raised a round of funding on December 10, 2013. Investors include
Asset Management Ventures.
Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. PCCs were…